References
- Ahad, A.; Raish, M.; Bin Jardan, Y. A.; Al-Mohizea, A. M.; Al-Jenoobi, F. I. Delivery of Insulin via Skin Route for the Management of Diabetes Mellitus: Approaches for Breaching the Obstacles. Pharmaceutics 2021, 13, 100. DOI: https://doi.org/10.3390/pharmaceutics13010100.
- Berna, G.; Oliveras-Lopez, M. J.; Jurado-Ruiz, E.; Tejedo, J.; Bedoya, F.; Soria, B.; Martin, F. Nutrigenetics and Nutrigenomics Insights into Diabetes Etiopathogenesis. Nutrients 2014, 6, 5338–5369. DOI: https://doi.org/10.3390/nu6115338.
- Ahad, A.; Al-Saleh, A. A.; Akhtar, N.; Al-Mohizea, A. M.; Al-Jenoobi, F. I. Transdermal Delivery of Antidiabetic Drugs: Formulation and Delivery Strategies. Drug. Discov. Today 2015, 20, 1217–1227. DOI: https://doi.org/10.1016/j.drudis.2015.06.002.
- Shrivastava, U.; Misra, A.; Mohan, V.; Unnikrishnan, R.; Bachani, D. Obesity, Diabetes and Cardiovascular Diseases in India: Public Health Challenges. Curr. Diabetes Rev. 2017, 13, 65–80. DOI: https://doi.org/10.2174/1573399812666160805153328.
- Pradeepa, R.; Mohan, V. Prevalence of Type 2 Diabetes and Its Complications in India and Economic Costs to the Nation. Eur. J. Clin. Nutr. 2017, 71, 816–824. DOI: https://doi.org/10.1038/ejcn.2017.40.
- Unnikrishnan, R.; Anjana, R. M.; Mohan, V. Diabetes Mellitus and Its Complications in India. Nat. Rev. Endocrinol. 2016, 12, 357–370. DOI: https://doi.org/10.1038/nrendo.2016.53.
- Sonia, T. A.; Sharma, C. P. An Overview of Natural Polymers for Oral Insulin Delivery. Drug. Discov. Today 2012, 17, 784–792. DOI: https://doi.org/10.1016/j.drudis.2012.03.019.
- Ahad, A.; Aqil, M.; Kohli, K.; Sultana, Y.; Mujeeb, M. Design, Formulation and Optimization of Valsartan Transdermal Gel Containing iso-eucalyptol as novel permeation enhancer: Preclinical assessment of pharmacokinetics in Wistar albino rats. Expert Opin. Drug. Deliv. 2014, 11, 1149–1162. DOI: https://doi.org/10.1517/17425247.2014.914027.
- Ahad, A.; Raish, M.; Al-Mohizea, A. M.; Al-Jenoobi, F. I.; Alam, M. A. Enhanced anti-Inflammatory Activity of Carbopol Loaded Meloxicam Nanoethosomes Gel. Int. J. Biol. Macromol. 2014, 67, 99–104. DOI: https://doi.org/10.1016/j.ijbiomac.2014.03.011.
- Chauhan, I.; Yasir, M.; Verma, M.; Singh, A. P. Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery. Adv. Pharm. Bull. 2020, 10, 150–165. DOI: https://doi.org/10.34172/apb.2020.021.
- Garces, A.; Amaral, M. H.; Sousa Lobo, J. M.; Silva, A. C. Formulations Based on Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for Cutaneous Use: A Review. Eur. J. Pharm. Sci. 2018, 112, 159–167. DOI: https://doi.org/10.1016/j.ejps.2017.11.023.
- Souto, E. B.; Baldim, I.; Oliveira, W. P.; Rao, R.; Yadav, N.; Gama, F. M.; Mahant, S. SLN and NLC for Topical, Dermal, and Transdermal Drug Delivery. Expert Opin. Drug. Deliv. 2020, 17, 357–377. DOI: https://doi.org/10.1080/17425247.2020.1727883.
- Iqbal, M. A.; Md, S.; Sahni, J. K.; Baboota, S.; Dang, S.; Ali, J. Nanostructured Lipid Carriers System: Recent Advances in Drug Delivery. J Drug Target. 2012, 20, 813–830. DOI: https://doi.org/10.3109/1061186X.2012.716845.
- Mu, H.; Holm, R. Solid Lipid Nanocarriers in Drug Delivery: Characterization and Design. Expert Opin. Drug. Deliv. 2018, 15, 771–785. DOI: https://doi.org/10.1080/17425247.2018.1504018.
- Gao, S.; Tian, B.; Han, J.; Zhang, J.; Shi, Y.; Lv, Q.; Li, K. Enhanced Transdermal Delivery of Lornoxicam by Nanostructured Lipid Carrier Gels Modified with Polyarginine Peptide for Treatment of Carrageenan-Induced Rat Paw Edema. IJN 2019, 14, 6135–6150. DOI: https://doi.org/10.2147/IJN.S205295.
- Mendes, M.; Nunes, S. C. C.; Sousa, J. J.; Pais, A.; Vitorino, C. Expanding Transdermal Delivery with Lipid Nanoparticles: A New Drug-in-NLC-in-Adhesive Design. Mol. Pharm. 2017, 14, 2099–2115. DOI: https://doi.org/10.1021/acs.molpharmaceut.7b00211.
- Chen, C. C.; Tsai, T. H.; Huang, Z. R.; Fang, J. Y. Effects of Lipophilic Emulsifiers on the Oral Administration of Lovastatin from Nanostructured Lipid Carriers: Physicochemical Characterization and Pharmacokinetics. Eur. J. Pharm. Biopharm. 2010, 74, 474–482. DOI: https://doi.org/10.1016/j.ejpb.2009.12.008.
- Ebrahimi, S.; Farhadian, N.; Karimi, M.; Ebrahimi, M. Enhanced Bactericidal Effect of Ceftriaxone Drug Encapsulated in Nanostructured Lipid Carrier against Gram-Negative Escherichia coli Bacteria: Drug Formulation, Optimization, and Cell Culture Study. Antimicrob. Resist. Infect. Control. 2020, 9, 28. DOI: https://doi.org/10.1186/s13756-020-0690-4.
- Salem, L. H.; El-Feky, G. S.; Fahmy, R. H.; El Gazayerly, O. N.; Abdelbary, A. Coated Lipidic Nanoparticles as a New Strategy for Enhancing Nose-to-Brain Delivery of a Hydrophilic Drug Molecule. J. Pharm. Sci. 2020, 109, 2237–2251. DOI: https://doi.org/10.1016/j.xphs.2020.04.007.
- Sharif Makhmal Zadeh, B.; Niro, H.; Rahim, F.; Esfahani, G. Ocular Delivery System for Propranolol Hydrochloride Based on Nanostructured Lipid Carrier. Sci. Pharm. 2018, 86, 16.
- Xia, M. Q.; Tian, C. L.; Liu, L.; Hu, R. F.; Gui, S. Y.; Chu, X. Q. Transdermal Administration of Ibuprofen-Loaded Gel: Preparation, Pharmacokinetic Profile, and Tissue Distribution. AAPS PharmSciTech. 2020, 21, 84. DOI: https://doi.org/10.1208/s12249-020-1627-1.
- Al-Omary, F. A. M. Gliclazide. Profiles Drug. Subst. Excip. Relat. Methodol. 2017, 42, 125–192. DOI: https://doi.org/10.1016/bs.podrm.2017.02.003.
- Palmer, K. J.; Brogden, R. N. Gliclazide. An Update of Its Pharmacological Properties and Therapeutic Efficacy in Non-Insulin-Dependent Diabetes Mellitus. Drugs 1993, 46, 92–125. DOI: https://doi.org/10.2165/00003495-199346010-00007.
- Singh, A. K.; Singh, R. Is Gliclazide a Sulfonylurea with Difference? A Review in 2016. Expert. Rev. Clin. Pharmacol. 2016, 9, 839–851. DOI: https://doi.org/10.1586/17512433.2016.1159512.
- Zhou, B.; Liu, S.; Yin, H.; Qi, M.; Hong, M.; Ren, G. B. Development of Gliclazide Ionic Liquid and the Transdermal Patches: An Effective and Noninvasive Sustained Release Formulation to Achieve Hypoglycemic Effects. Eur. J. Pharm. Sci. 2021, 164, 105915. DOI: https://doi.org/10.1016/j.ejps.2021.105915.
- Uprit, S.; Kumar Sahu, R.; Roy, A.; Pare, A. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carrier Gel for Effective Treatment of Alopecia. Saudi Pharm. J. 2013, 21, 379–385. DOI: https://doi.org/10.1016/j.jsps.2012.11.005.
- Kumar, A.; Singh, A.; Flora, S. J. S.; Shukla, R. Box-Behnken Design Optimized TPGS Coated Bovine Serum Albumin Nanoparticles Loaded with Anastrozole. Curr. Drug Deliv. 2021, 18, 1136–147.
- Singh, A.; Vaishagya, K.; R, K. V.; Shukla, R. Temperature/pH-Triggered PNIPAM-Based Smart Nanogel System Loaded with Anastrozole Delivery for Application in Cancer Chemotherapy. AAPS PharmSciTech 2019, 20, 213. DOI: https://doi.org/10.1208/s12249-019-1410-3.
- Thapa, C.; Ahad, A.; Aqil, M.; Imam, S. S.; Sultana, Y. Formulation and Optimization of Nanostructured Lipid Carriers to Enhance Oral Bioavailability of Telmisartan Using Box–Behnken Design. J. Drug Deliv. Sci. Technol. 2018, 44, 431–439. DOI: https://doi.org/10.1016/j.jddst.2018.02.003.
- Biswal, S.; Sahoo, J.; Murthy, P. N. Characterisation of gliclazide-PEG 8000 Solid Dispersions. Trop. J. Pharm. Res. 2009, 8, 417–424.
- Nnamani, P. O.; Hansen, S.; Windbergs, M.; Lehr, C. M. Development of Artemether-Loaded Nanostructured Lipid Carrier (NLC) Formulation for Topical Application. Int. J. Pharm. 2014, 477, 208–217. DOI: https://doi.org/10.1016/j.ijpharm.2014.10.004.
- Cirri, M.; Maestrini, L.; Maestrelli, F.; Mennini, N.; Mura, P.; Ghelardini, C.; Di Cesare Mannelli, L. Design, Characterization and In Vivo Evaluation of Nanostructured Lipid Carriers (NLC) as a New Drug Delivery System for Hydrochlorothiazide Oral Administration in Pediatric Therapy. Drug Deliv. 2018, 25, 1910–1921. DOI: https://doi.org/10.1080/10717544.2018.1529209.
- Negi, L. M.; Jaggi, M.; Talegaonkar, S. Development of Protocol for Screening the Formulation Components and the Assessment of Common Quality Problems of Nano-Structured Lipid Carriers. Int. J. Pharm. 2014, 461, 403–410. DOI: https://doi.org/10.1016/j.ijpharm.2013.12.006.
- Rizwanullah, M.; Amin, S.; Ahmad, J. Improved Pharmacokinetics and Antihyperlipidemic Efficacy of Rosuvastatin-Loaded Nanostructured Lipid Carriers. J. Drug Target. 2017, 25, 58–74. DOI: https://doi.org/10.1080/1061186X.2016.1191080.
- Ahad, A.; Aqil, M.; Kohli, K.; Sultana, Y.; Mujeeb, M. Enhanced Transdermal Delivery of an anti-Hypertensive Agent via Nanoethosomes: Statistical Optimization, Characterization and Pharmacokinetic Assessment. Int. J. Pharm. 2013, 443, 26–38. DOI: https://doi.org/10.1016/j.ijpharm.2013.01.011.
- Ahad, A.; Aqil, M.; Kohli, K.; Sultana, Y.; Mujeeb, M.; Ali, A. Formulation and Optimization of Nanotransfersomes Using Experimental Design Technique for Accentuated Transdermal Delivery of Valsartan. Nanomedicine 2012, 8, 237–249. DOI: https://doi.org/10.1016/j.nano.2011.06.004.
- Kovacs, A.; Berko, S.; Csanyi, E.; Csoka, I. Development of Nanostructured Lipid Carriers Containing Salicyclic Acid for Dermal Use Based on the Quality by Design Method. Eur. J. Pharm. Sci. 2017, 99, 246–257.
- Ahad, A.; Raish, M.; Ahmad, A.; Al-Jenoobi, F. I.; Al-Mohizea, A. M. Eprosartan Mesylate Loaded Bilosomes as Potential Nano-Carriers against Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats. Eur. J. Pharm. Sci. 2018, 111, 409–417. DOI: https://doi.org/10.1016/j.ejps.2017.10.012.
- Ahad, A.; Raish, M.; Al-Jenoobi, F. I.; Al-Mohizea, A. M. Sorbitane Monostearate and Cholesterol Based Niosomes for Oral Delivery of Telmisartan. Curr Drug Deliv. 2018, 15, 260–266. DOI: https://doi.org/10.2174/1567201814666170518131934.
- Ahad, A.; Raish, M.; Ahmad, A.; Al-Jenoobi, F. I.; Al-Mohizea, A. M. Development and Biological Evaluation of Vesicles Containing Bile Salt of Telmisartan for the Treatment of Diabetic Nephropathy. Artif. Cells. Nanomed. Biotechnol. 2018, 46, 532–539. DOI: https://doi.org/10.1080/21691401.2018.1430700.
- Hanna, P. A.; Ghorab, M. M.; Gad, S. Development of Betamethasone Dipropionate-Loaded Nanostructured Lipid Carriers for Topical and Transdermal Delivery. Antiinflamm. Antiallergy Agents Med. Chem. 2019, 18, 26–44. DOI: https://doi.org/10.2174/1871523017666181115104159.
- Silva, L. A.; Andrade, L. M.; de Sa, F. A.; Marreto, R. N.; Lima, E. M.; Gratieri, T.; Taveira, S. F. Clobetasol-Loaded Nanostructured Lipid Carriers for Epidermal Targeting. J. Pharm. Pharmacol. 2016, 68, 742–750. DOI: https://doi.org/10.1111/jphp.12543.
- Nagaich, U.; Gulati, N. Nanostructured Lipid Carriers (NLC) Based Controlled Release Topical Gel of Clobetasol Propionate: Design and In Vivo Characterization. Drug Deliv. Transl. Res. 2016, 6, 289–298. DOI: https://doi.org/10.1007/s13346-016-0291-1.
- Teng, Z.; Yu, M.; Ding, Y.; Zhang, H.; Shen, Y.; Jiang, M.; Liu, P.; Opoku-Damoah, Y.; Webster, T. J.; Zhou, J. Preparation and Characterization of Nimodipine-Loaded Nanostructured Lipid Systems for Enhanced Solubility and Bioavailability. Int. J. Nanomedicine. 2019, 14, 119–133. DOI: https://doi.org/10.2147/IJN.S186899.
- Jagdale, S.; Chaudhari, B. Optimization of Microemulsion Based Transdermal Gel of Triamcinolone. Recent Pat. Antiinfect. Drug Discov. 2017, 12, 61–78.
- Sita, V. G.; Vavia, P. Bromocriptine Nanoemulsion-Loaded Transdermal Gel: Optimization Using Factorial Design, In Vitro and In Vivo Evaluation. AAPS PharmSciTech. 2020, 21, 80. DOI: https://doi.org/10.1208/s12249-020-1620-8.
- Dantas, M. G.; Reis, S. A.; Damasceno, C. M.; Rolim, L. A.; Rolim-Neto, P. J.; Carvalho, F. O.; Quintans-Junior, L. J.; Almeida, J. R. Development and Evaluation of Stability of a Gel Formulation Containing the Monoterpene Borneol. Sci. World J. 2016, 2016, 7394685. DOI: https://doi.org/10.1155/2016/7394685.
- Kaur, N.; Sharma, K.; Bedi, N. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis. Pharm. Nanotechnol. 2018, 6, 133–143. DOI: https://doi.org/10.2174/2211738506666180523112513.
- Keshri, L.; Pathak, K. Development of Thermodynamically Stable Nanostructured Lipid Carrier System Using Central Composite Design for Zero Order Permeation of Econazole Nitrate through Epidermis. Pharm. Dev. Technol. 2013, 18, 634–644. DOI: https://doi.org/10.3109/10837450.2012.659256.
- Loo, C.; Basri, M.; Ismail, R.; Lau, H.; Tejo, B.; Kanthimathi, M.; Hassan, H.; Choo, Y. Effect of Compositions in Nanostructured Lipid Carriers (NLC) on Skin Hydration and Occlusion. Int. J. Nanomedicine. 2013, 8, 13–22. DOI: https://doi.org/10.2147/IJN.S35648.
- Motawea, A.; Borg, T.; Abd El-Gawad, A. E. H. Topical Phenytoin Nanostructured Lipid Carriers: Design and Development. Drug Dev. Ind. Pharm. 2018, 44, 144–157. DOI: https://doi.org/10.1080/03639045.2017.1386204.
- Souto, E. B.; Wissing, S. A.; Barbosa, C. M.; Muller, R. H. Evaluation of the Physical Stability of SLN and NLC before and after Incorporation into Hydrogel Formulations. Eur. J. Pharm. Biopharm. 2004, 58, 83–90. DOI: https://doi.org/10.1016/j.ejpb.2004.02.015.
- Jain, K.; Sood, S.; Gowthamarajan, K. Optimization of Artemether-Loaded NLC for Intranasal Delivery Using Central Composite Design. Drug Deliv. 2015, 22, 940–954. DOI: https://doi.org/10.3109/10717544.2014.885999.
- Siddiqui, A.; Alayoubi, A.; El-Malah, Y.; Nazzal, S. Modeling the Effect of Sonication Parameters on Size and Dispersion Temperature of Solid Lipid Nanoparticles (SLNs) by Response Surface Methodology (RSM). Pharm. Dev. Technol. 2014, 19, 342–346. DOI: https://doi.org/10.3109/10837450.2013.784336.
- Akhoond Zardini, A.; Mohebbi, M.; Farhoosh, R.; Bolurian, S. Production and Characterization of Nanostructured Lipid Carriers and Solid Lipid Nanoparticles Containing Lycopene for Food Fortification. J Food Sci Technol. 2018, 55, 287–298. DOI: https://doi.org/10.1007/s13197-017-2937-5.
- Thatipamula, R.; Palem, C.; Gannu, R.; Mudragada, S.; Yamsani, M. Formulation and In Vitro Characterization of Domperidone Loaded Solid Lipid Nanoparticles and Nanostructured Lipid Carriers. Daru 2011, 19, 23–32.
- Nayak, K.; Katiyar, S. S.; Kushwah, V.; Jain, S. Coenzyme Q10 and Retinaldehyde co-Loaded Nanostructured Lipid Carriers for Efficacy Evaluation in Wrinkles. J. Drug Target. 2018, 26, 333–344. DOI: https://doi.org/10.1080/1061186X.2017.1379527.